← All trials
NCT04309656
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 14, 2020
- Primary completion
- Feb 28, 2020
- Completion date
- Feb 28, 2020
- First posted
- Mar 16, 2020
- Last posted
- Mar 16, 2020
- Enrollment
- 48
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Global Alliance for TB Drug DevelopmentLead sponsor
- World Wide Clinical Trials Early Phase Services, LLCOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.